Cargando…
Contemporary Validation of a Nomogram Predicting Colon Cancer Recurrence, Revealing All-Stage Improved Outcomes
BACKGROUND: The Memorial Sloan Kettering Cancer Center (MSK) colon cancer recurrence nomogram is a risk calculator that provides patients and clinicians with individualized prediction of recurrence following curative resection of colon cancer. Although validated on multiple separate cohorts, the nom...
Autores principales: | Konishi, Tsuyoshi, Shimada, Yoshifumi, Hsu, Meier, Wei, Iris H, Pappou, Emmanouil, Smith, J Joshua, Nash, Garrett M, Guillem, José G, Paty, Philip B, Garcia-Aguilar, Julio, Cercek, Andrea, Yaeger, Rona, Stadler, Zsofia K, Segal, Neil H, Varghese, Anna, Saltz, Leonard B, Shia, Jinru, Vakiani, Efsevia, Gönen, Mithat, Weiser, Martin R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6512350/ https://www.ncbi.nlm.nih.gov/pubmed/31119207 http://dx.doi.org/10.1093/jncics/pkz015 |
Ejemplares similares
-
Quantitative assessment of tumor-infiltrating lymphocytes in mismatch repair proficient colon cancer
por: Jimenez-Rodriguez, Rosa M., et al.
Publicado: (2020) -
Survival After Induction Chemotherapy and Chemoradiation Versus Chemoradiation and Adjuvant Chemotherapy for Locally Advanced Rectal Cancer
por: Kim, Jin K, et al.
Publicado: (2022) -
Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions
por: Brannon, A Rose, et al.
Publicado: (2014) -
Recurrent, truncating SOX9 mutations are associated with SOX9 overexpression, KRAS mutation, and TP53 wild type status in colorectal carcinoma
por: Javier, Breanna M., et al.
Publicado: (2016) -
A Dynamic Clinical Calculator for Estimating Conditional Recurrence-Free Survival After Total Neoadjuvant Therapy for Rectal Cancer and Either Surgery or Watch-and-Wait Management
por: Weiser, Martin R., et al.
Publicado: (2022)